Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Cash from Financing Activities (2016 - 2025)

Macrogenics (MGNX) has disclosed Cash from Financing Activities for 14 consecutive years, with $57000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 63.23% to $57000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $69.5 million, a 7141.04% increase, with the full-year FY2025 number at $69.5 million, up 7141.04% from a year prior.
  • Cash from Financing Activities was $57000.0 for Q4 2025 at Macrogenics, down from $69.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $100.7 million in Q1 2021 to a low of -$282000.0 in Q1 2025.
  • A 5-year average of $19.2 million and a median of $449000.0 in 2023 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: soared 270489.19% in 2023, then tumbled 213.71% in 2025.
  • Macrogenics' Cash from Financing Activities stood at $800000.0 in 2021, then surged by 69.88% to $1.4 million in 2022, then plummeted by 79.91% to $273000.0 in 2023, then crashed by 43.22% to $155000.0 in 2024, then plummeted by 63.23% to $57000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Cash from Financing Activities are $57000.0 (Q4 2025), $69.7 million (Q2 2025), and -$282000.0 (Q1 2025).